NCT07693283 Expression of Target in Endometriotic Lesions
| NCT ID | NCT07693283 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Beijing Tsinghua Chang Gung Hospital |
| Condition | Endometriosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 40 participants |
| Start Date | 2026-04-13 |
| Primary Completion | 2026-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 40 participants in total. It began in 2026-04-13 with a primary completion date of 2026-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Endometriosis is a common gynecological disorder associated with chronic pelvic pain and infertility, which affects women of reproductive age worldwide. This study aims to investigate the expression patterns of specific molecules in tissue specimens obtained from patients with endometriosis. The investigators will compare the expression levels of these molecules between endometriotic lesions and normal tissue. The primary objective of this study is to elucidate the potential roles of these molecules in the pathogenesis of endometriosis.
Eligibility Criteria
Inclusion Criteria: * Pathologically confirmed endometriosis via laparoscopy and histopathological examination * Complete clinical and pathological data available Exclusion Criteria: • History of any malignant tumor
Contact & Investigator
Lei Zhang
PRINCIPAL INVESTIGATOR
Beijing Tsinghua Changgeng Hospital
Frequently Asked Questions
Who can join the NCT07693283 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 50 Years, studying Endometriosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07693283 currently recruiting?
Yes, NCT07693283 is actively recruiting participants. Contact the research team at 461458953@qq.com for enrollment information.
Where is the NCT07693283 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT07693283 clinical trial?
NCT07693283 is sponsored by Beijing Tsinghua Chang Gung Hospital. The principal investigator is Lei Zhang at Beijing Tsinghua Changgeng Hospital. The trial plans to enroll 40 participants.